Robert Uzzo, MD, MBA, FACS

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427
Huntingdon Pike
8 Huntingdon Pike
Rockledge, PA 19046
Phone: 888-369-2427

President & CEO, Fox Chase Cancer Center

Executive Vice President for Cancer Services – Temple University Health System

Senior Associate Dean, Clinical Cancer Research – Lewis Katz School of Medicine at Temple University

G. Willing "Wing" Pepper Chair in Cancer Research

Specialties

Urology

Areas of Expertise

Adrenal Tumor, Penile Cancer, Ureteral Cancer, Kidney Cancer, Testicular Cancer, Bladder Cancer, Prostate Cancer, Urethral Cancer

Treatment Focus

Robotic and laparoscopic urologic oncology
Organ preservation (kidney, bladder, testicular and adrenal)
Non-surgical management of low risk urinary tumors
Complex urological reconstruction

Research Program

Nuclear Dynamics and Cancer

Distinctions

Treatment Philosophy

I believe in treating patients as I would my own family. I strive to communicate effectively with patients and family members at all levels. Through extensive discussions with my patients, I develop treatment plans that are both effective and acknowledge that quality of life issues are exceptionally important. I emphasize individually tailored treatments to help patients achieve success and limit treatment-related side effects which can affect quality of life.

I am sensitive to the particular issues regarding surgical treatment of genitourinary cancer, especially the physical and emotional effects on patients and their family. By fostering a doctor-patient relationship based on mutual respect and open dialogue, I encourage patients to become empowered managers of their care... Expand

As a fellowship-trained laparoscopic and robotic urologic oncologist, I am specially trained in nerve-sparing, organ sparing and organ reconstructive surgical techniques for men and women. These strategies are essential for preserving normal functions. For instance, I perform kidney sparing surgery whenever possible to avoid future risks of dialysis. For prostate or testicular surgery, nerve preservation is essential; and when bladder removal is necessary, reconstruction of a new (neobladder) is my preferred approach.

Professionally, I have published more than 300 journal papers in urologic oncology and have lectured extensively regionally, nationally and internationally on the topics of kidney, prostate, bladder, and testicular cancer. I am the principle investigator or co-investigator on multiple national and regional clinical trials in urologic oncology. Because of my research and extensive membership in professional organizations, I am among the first to know what is new in urologic cancer treatment. Philadelphia magazine has chosen me for its "Top Doctors" list every year since 2002. Collapse

Bio

As President & CEO, Fox Chase Cancer Center, Robert Uzzo is responsible for leading the overall clinical operations of Fox Chase.

In addition to these roles, Uzzo is the G. Willing “Wing” Pepper Chair in Cancer Research and also serves as the organization’s President of the Medical Group. He also serves as the founding Executive Director of the nation’s second largest urologic quality collaborative, the Pennsylvania Urologic Regional Collaborative.

... Expand

Educational Background

Fellow, Urologic Oncology, Cleveland Clinic Foundation
Fellow, Renal Transplantation and Renovascular Surgery, Cleveland Clinic Foundation
Chief Resident, Urology, New York Hospital-Cornell University Medical Center, New York, NY
Senior Resident, Urology, Memorial Sloan-Kettering Cancer Center, New York, NY
MD, Cornell Medical College, New York, NY, 1991
BS/BA, Union College, Schenectady, NY, 1987, Valedictorian

Certifications

American Board of Urology

Memberships

The American Urological Association
Member, American Association of Genitourinary Surgeons, AAGUS
Society of Urologic Oncology, Board of Directors
Society of Urologic Oncology, Clinical Trials Consortium, President
Society of Urologic Oncology, Clinical Trials Consortium, Renal Program Chairman
Board of Directors, SUO Clinical Trials Consortia, member-at-large
Fox Chase Cancer Center Society of Scholars
Kidney Cancer Association Medical Advisory Board
Fellow American College of Surgeons (F.A.C.S.)
Society of Urologic Oncology
Pennsylvania Medical Society
Philadelphia County Medical Society
The MidAtlantic Section of the American Urological Association
Eastern Cooperative Oncology Group
Radiation Therapy Oncology Group
American College of Surgeons Oncology Group - Vice Chairman, GU Organ Committee 2002-2006
American Society of Transplant Surgeons
Urologic Society of Transplant and Vascular Surgeons
Society for Basic Urologic Research
American Association for Cancer Research

Honors & Awards

Philadelphia Magazine Top Doctors, 2002-24
Best Doctors in America^®, 2013-16, 2019-2020, Urology
America’s Top Doctors^®, 2008-17
AUA Residents National Committee Teaching Award
Consumer’s Research Council of America –America’s Top Physicians

Link to /sites/default/files/styles/patient_story/public/images/patient-stories/PHilSanchezHeadshot-resize.jpg?h=261d95a3&itok=NfCRQqdO

Felix (Phil) Sanchez

Bladder Cancer

I follow up with people and act as a mentor. I let them know they are able to contact me at any time, and I can offer them peace of mind from someone who has been where they are headed.

VIEW PATIENT STORY

Research Interests

Clinical and translational questions involving renal cell carcinoma including decision making models in the management of renal cancers and processes/quality of care in urologic malignancies
Analyses of outcomes involving excision, ablation, and active surveillance for localized kidney cancer and techniques/outcomes of surgery in locally advanced and metastatic RCC
Actively develop and accrue to multiple industry sponsored national and international urological oncology trials as well as investigator initiated trials.
Translational interests include biomarker development in kidney cancer and the role of zinc dyshomeostasis in prostate cancer

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 14.0px Calibri; -webkit-text-stroke: #000000} span.s1 {font-kerning: none}

Selected Publications

Chapters and Publications from over 400:

Correa A.F., Jegede O.A., Haas N.B., Flaherty K.T., Pins M.R., Adeniran A., Messing E.M., Manola J., Wood C.G., Kane C.J., Jewett M.A.S., Dutcher J.P., DiPaola R.S., Carducci M.A., Uzzo R.G., Predicting disease recurrence, early progression, and overall survival following surgical resection for high-risk localized and locally advanced renal cell carcinoma. Eur Urol. 80(1): 20-31, 2021. PMC8627688. https://www.ncbi.nlm.nih.gov/pubmed/33707112.

Smith S.M., Wachter K., Burris H.A., 3rd, Schilsky R.L., George D.J., Peterson D.E., Johnson M.L., Markham M.J., Mileham K.F., Beg M.S., Bendell J.C., Dreicer R., Keedy V.L., Kimple R.J., Knoll M.A., LoConte N., MacKay H., Meisel J.L., Moynihan T.J., Mulrooney D.A., Mulvey T.M., Odenike O., Pennell N.A., Reeder-Hayes K., Smith C., Sullivan R.J., Uzzo R., Clinical cancer advances 2021: Asco's report on progress against cancer. J Clin Oncol. 39(10): 1165-1184, 2021. https://www.ncbi.nlm.nih.gov/pubmed/33527845.

Campbell S.C., Novick A.C., Belldegrun A., Blute M.L., Chow G.K., Derweesh I.H., Faraday M.M., Kaouk J.H., Leveillee R.J., Matin S.F., Russo P., Uzzo R.G., Guideline for Management of the Clinical T1 Renal Mass, 2009, Journal of Urology, 182, 4 SUPPL., 1271, 1279 PubMed

Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery? Journal of Surgical Research, 231:242-7, 2018.

Uzzo R.G., Novick A.C., Nephron sparing surgery for renal tumors: Indications, techniques and outcomes, 2001, Journal of Urology, 166, 1, 6, 18 PubMed

Kutikov A, Uzzo RG. The RENAL Nephrometry Score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol, 182(3):844-53, 2009. (cited 401 times) PubMed

Chawla S.N., Crispen P.L., Hanlon A.L., Greenberg R.E., Chen D.Y.T., Uzzo R.G., The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature, 2006, Journal of Urology, 175, 2, 425, 431 PubMed

Kunkle D.A., Egleston B.L., Uzzo R.G., Excise, Ablate or Observe: The Small Renal Mass Dilemma-A Meta-Analysis and Review, 2008, Journal of Urology, 179, 4, 1227, 1234 PubMed

Kunkle D.A., Uzzo R.G., Cryoablation or radiofrequency ablation of the small renal mass: A meta-analysis, 2008, Cancer, 113, 10, 2671, 2680 PubMed

Uzzo R.G., Wei J.T., Waldbaum R.S., Perlmutter A.P., Byrne J.C., Vaughan Jr. D., The influence of prostate size on cancer detection, 1995, Urology, 46, 6, 831, 836 PubMed

... Expand

Additional Publications

My NCBI

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.